Amended Report No.12 was filed, reportedly indicating that Growth Capital had reduced its stake in MetReX (メドレックス). The subject stock is Medrx, and the report number is provided.
The publication of Amended Report No.12 disclosed that Growth Capital had reduced its stake in Medrx. The article reports the scale of the decline in the stake and the date as of which the data was based.
This move indicates a change in Medrx's shareholder composition, and the information was shared with other market participants through its publication as an amended report.
The matter is treated as an event indicating a change in the shareholder composition of an individual stock. Whether further updates will be issued may depend on additional disclosures and the publication of related information.